Cargando…

Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms

Randomized clinical trials (RCTs) are the gold standard in producing clinical evidence of efficacy and safety of medical interventions. More recently, a new paradigm is emerging—specifically within the context of preauthorization regulatory decision‐making—for some novel uses of real‐world evidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burcu, Mehmet, Dreyer, Nancy A., Franklin, Jessica M., Blum, Michael D., Critchlow, Cathy W., Perfetto, Eleanor M., Zhou, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687199/ https://www.ncbi.nlm.nih.gov/pubmed/32162381 http://dx.doi.org/10.1002/pds.4975

Ejemplares similares

Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary
por: Girman, Cynthia J., et al.
Publicado: (2018)

The Use of External Controls in FDA Regulatory Decision Making
por: Jahanshahi, Mahta, et al.
Publicado: (2021)

Real-world evidence for regulatory decision-making: updated guidance from around the world
por: Burns, Leah, et al.
Publicado: (2023)

Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019)

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
por: Bakker, Elisabeth, et al.
Publicado: (2022)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

Modernizing Regulatory Evidence with Trials and Real-World Studies
por: Dreyer, Nancy A., et al.
Publicado: (2020)

Considerations when evaluating real‐world data quality in the context of fitness for purpose
por: Reynolds, Matthew W., et al.
Publicado: (2020)

Transferability of real-world data across borders for regulatory and health technology assessment decision-making
por: Jaksa, Ashley, et al.
Publicado: (2022)

Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations
por: Tan, W. Katherine, et al.
Publicado: (2022)

Tactical Considerations for Designing Real-World Studies: Fit-for-Purpose Designs That Bridge Research and Practice
por: Dreyer, Nancy A, et al.
Publicado: (2023)

Smog, Cognition and Real-World Decision-Making
por: Chen, Xi
Publicado: (2018)

Real-world evidence enhances decision making
por: Malone, Daniel C
Publicado: (2020)

Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations
por: Horton, Daniel B., et al.
Publicado: (2021)

EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making
por: Plueschke, Kelly, et al.
Publicado: (2018)

The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making
por: Baumfeld Andre, Elodie, et al.
Publicado: (2022)

Pharmacoepidemiology Research-Real-World Evidence for Decision Making
por: Bérard, Anick
Publicado: (2021)

Considerations of Mutual Exchange in Prosocial Decision-Making
por: Allidina, Suraiya, et al.
Publicado: (2019)

Real world data: Additional source for making clinical decisions
por: Mahajan, Rajiv
Publicado: (2015)

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
por: Jang, Ha Young, et al.
Publicado: (2022)

Patient-Community Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust
por: Oehrlein, Elisabeth M., et al.
Publicado: (2019)

Children’s externalizing and internalizing symptoms and their involvement in decision-making
por: Németh, B., et al.
Publicado: (2022)

Integrating Value Considerations in the Decision Making for the Design of Biorefineries
por: Palmeros Parada, Mar, et al.
Publicado: (2020)

USING REAL-WORLD EVIDENCE TO SUPPORT THE FDA REGULATORY APPROVAL: METHODOLOGICAL CONSIDERATIONS
por: Lu, Kevin, et al.
Publicado: (2022)

Trial designs using real‐world data: The changing landscape of the regulatory approval process
por: Baumfeld Andre, Elodie, et al.
Publicado: (2019)

Real-world data mining : applied business analytics and decision making
por: Delen, Dursun
Publicado: (2014)

Race and Ethnicity in Real-World Data Sources: Considerations for Medical Device Regulatory Efforts
por: Tarver, Michelle E.
Publicado: (2021)

Judicial breakfast as an external factor in judicial decision making in courts
por: Tampubolon, Manotar, et al.
Publicado: (2023)

A PRACTICE FRAMEWORK FOR CONSIDERATION OF GENDER IN ETHICAL DECISION-MAKING
por: Bowland, Sharon, et al.
Publicado: (2019)

Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products
por: Girman, Cynthia J., et al.
Publicado: (2022)

Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials
por: Seeger, John D., et al.
Publicado: (2020)

Supporting Real World Decision Making in Coronary Diseases Using Machine Learning
por: Kokol, Peter, et al.
Publicado: (2021)

Accounting for multiscale processing in adaptive real-world decision-making via the hippocampus
por: Mehrotra, Dhruv, et al.
Publicado: (2023)

Payer perceptions of the use of real-world evidence in oncology-based decision making
por: Brixner, Diana, et al.
Publicado: (2021)

Discussion of Race and Ethnicity in Real-World Data Sources: Considerations for Medical Device Regulatory Efforts
por: Hamidian Jahromi, Alireza, et al.
Publicado: (2021)

Access to Chemical Data Used in Regulatory Decision Making
por: Goldman, Lynn R., et al.
Publicado: (2013)

The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
por: Khunti, Kamlesh, et al.
Publicado: (2023)

Novel Approaches to Identification of Biomarkers for Detection of Early Stage Cancer
por: Kiviat, Nancy B., et al.
Publicado: (2002)

Scientific and Societal Considerations in Selecting Assessment Endpoints for Environmental Decision Making
por: Strange, Elizabeth M., et al.
Publicado: (2002)

The Extremely Preterm Infant: Ethical Considerations in Life-and-Death Decision-Making
por: Albersheim, Susan
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ra7darttpo44gar5653nfmusr9